Historical neurotoxins: What we have learned from toxins of the past about diseases of the present

Neurologic Clinics

Volumn 23, Issue 2, 2005, Pages 337-352

  Rusyniak, Daniel E ^a,b   Furbee, R Brent ^a   Pascuzzi, Robert ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPROPIONOXYPIPERIDINE; 1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ANTIDEPRESSANT AGENT; ANTIFUNGAL AGENT; BENZATROPINE MESILATE; CLARITHROMYCIN; DIAMORPHINE; DIHYDROERGOTAMINE; DIPHENHYDRAMINE; DOPAMINE UPTAKE INHIBITOR; ERGOMETRINE; ERGOT ALKALOID; ERGOTAMINE; ERYTHROMYCIN; FLUCONAZOLE; FLUOXETINE; GINGER EXTRACT; KETOCONAZOLE; LEVODOPA; MACROLIDE; METHYLMERCURY; MONOAMINE OXIDASE B INHIBITOR; NEUROTOXIC ESTERASE; NEUROTOXIN; PETHIDINE; PHENOTHIAZINE; PIPERIDINE DERIVATIVE; PROTEINASE INHIBITOR; TRI ORTHO CRESYL PHOSPHATE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ALCOHOLIC BEVERAGE; AMYOTROPHIC LATERAL SCLEROSIS; ATAXIA; AUTOPSY; BLOOD PLACENTA BARRIER; BREAD; BURNING SENSATION; CAT; CATATONIC SCHIZOPHRENIA; CENTRAL NERVOUS SYSTEM DISEASE; CEREBELLAR ATAXIA; CEREBRAL PALSY; CHOREA; CLINICAL FEATURE; COMPENSATION; COURT; DEMYELINATION; DEVELOPMENTAL DISORDER; DIARRHEA; DIET; DRUG ABUSE; DRUG CONTAMINATION; DRUG CONTRAINDICATION; DRUG DEPENDENCE; DRUG METABOLISM; DYSARTHRIA; ELECTROCONVULSIVE THERAPY; EPIDEMIC; ERGOTISM; EUPHORIA; EXPERIMENTAL MODEL; EXPOSURE; EXTRAPYRAMIDAL SYNDROME; FATIGUE; FETAL TISSUE TRANSPLANTATION; FISH; FISHING; FOOD CONTAMINATION; GINGER; HALLUCINATION; HEARING IMPAIRMENT; HEATING; HISTORY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERSALIVATION; IMMOBILIZATION; INTOXICATION; LAW; LEG CRAMP; LIMB MALFORMATION; MALAISE; MENTAL DEFICIENCY; MENTAL DISEASE; MERCURIALISM; METABOLISM; MICROCEPHALY; MIGRAINE; MINAMATA DISEASE; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOTOR NEURON DISEASE; MOTOR NEUROPATHY; MUSCLE WEAKNESS; NAUSEA; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NEUROTOXICOLOGY; NONHUMAN; PARALYSIS; PARAPLEGIA; PARESTHESIA; PARKINSON DISEASE; PARKINSONISM; PATENT; PERIPHERAL EDEMA; PERIPHERAL NEUROPATHY; POLLUTION; POLYNEUROPATHY; POSTPARTUM HEMORRHAGE; PRENATAL EXPOSURE; PRIORITY JOURNAL; RECYCLING; REFLEX DISORDER; REVIEW; SEA POLLUTION; SEIZURE; SENSORIMOTOR NEUROPATHY; SIDE EFFECT; SKIN TINGLING; STILLBIRTH; SUBSTANTIA NIGRA; TREATMENT FAILURE; TREATMENT OUTCOME; TREMOR; UNITED STATES; VASOCONSTRICTION; VISUAL FIELD DEFECT; VOMITING; WASTE WATER; WATER CONTAMINATION; WITCHCRAFT;

EID: 14744289899     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2004.12.012     Document Type: Review

References (58)

1. B.K. Nelson Adult versus developmental neurotoxicology: an occupational perspective of similarities and differences Neurotoxicol Teratol 16 1994 213 218
2. US Congress, Office of Technology Assessment, Neurotoxicity Identifying and controlling poisons of the nervous system, OTA-BA-436 April 1990 US Government Printing Office Washington, DC
3. D.L. Eisenbrandt, S.L. Allen, and P.H. Berry Evaluation of the neurotoxic potential of chemicals in animals Food Chem Toxicol 32 1994 655 669
4. F. Fung, R. Clark, and S. Williams Stachybotrys, a mycotoxin-producing fungus of increasing toxicologic importance J Toxicol Clin Toxicol 36 1998 79 86
5. P.R. Lees-Haley Toxic mold and mycotoxins in neurotoxicity cases: Stachybotrys, Fusarium, Trichoderma, Aspergillus, Penicillium, Cladosporium, Alternaria, Trichothecenes Psychol Rep 93 2003 561 584
6. D.E. Lilienfeld, E. Chan, and J. Ehland Two decades of increasing mortality from Parkinson's disease among the US elderly Arch Neurol 47 1990 731 734
7. D.E. Lilienfeld, E. Chan, and J. Ehland Rising mortality from motoneuron disease in the USA, 1962-84 Lancet 1 1989 710 713
8. J.P. Morgan The Jamaica ginger paralysis JAMA 248 1982 1864 1867
9. D. Baum Jake leg New Yorker 15 2003 50 57
10. J. Parascandola The Public Health Service and Jamaica ginger paralysis in the 1930s Public Health Rep 110 1995 361 363
11. J.P. Morgan, and T.C. Tulloss The Jake Walk Blues. A toxicologic tragedy mirrored in American popular music Ann Intern Med 85 1976 804 808
12. P.M. Wax Elixirs, diluents, and the passage of the 1938 Federal Food, Drug and Cosmetic Act Ann Intern Med 122 1995 456 461
13. D.H. Werden Ascending paralysis resulting from the drinking of "Jamaica ginger"; a clinical study of fifty cases Ann Intern Med 5 1932 1257 1266
14. M. Lotti, C.E. Becker, and M.J. Aminoff Organophosphate polyneuropathy: pathogenesis and prevention Neurology 34 1984 658 662
15. J.P. Morgan, and P. Penovich Jamaica ginger paralysis. Forty-seven-year follow-up Arch Neurol 35 1978 530 532
16. S. Sevim, M. Aktekin, and O. Dogu Late onset polyneuropathy due to organophosphate (DDVP) intoxication Can J Neurol Sci 30 2003 75 78
17. C.C. Chuang, T.S. Lin, and M.C. Tsai Delayed neuropathy and myelopathy after organophosphate intoxication N Engl J Med 347 2002 1119 1121
18. C. Vasilescu, and A. Florescu Clinical and electrophysiological study of neuropathy after organophosphorus compounds poisoning Arch Toxicol 43 1980 305 315
19. P.S. Spencer, H.H. Schaumburg, and M.I. Sabri The enlarging view of hexacarbon neurotoxicity Crit Rev Toxicol 7 1980 279 356
20. P. Glynn Neuropathy target esterase Biochem J 344 1999 625 631
21. M. Lotti, and M.K. Johnson Neurotoxicity of organophosphorus pesticides: predictions can be based on in vitro studies with hen and human enzymes Arch Toxicol 41 1978 215 221
22. D.E. Rusyniak, R.B. Furbee, and M.A. Kirk Thallium and arsenic poisoning in a small midwestern town Ann Emerg Med 39 2002 307 311
23. M. Lotti, C.E. Becker, and M.J. Aminoff Occupational peripheral neuropathies West J Med 137 1982 493 498
24. E.S. Reynolds An account of the epidemic outbreak of arsenical pisoning occurring in beer drinkers in the North of England during the year 1900 Lancet i 1901 166 170
25. D.O. Hryhorczuk, S.E. Aks, and J.W. Turk Unusual occupational toxins Occup Med 7 1992 567 586
26. R. Burns, D.W. Thomas, and V.J. Barron Reversible encephalopathy possibly associated with bismuth subgallate ingestion Br Med J 1 1974 220 223
27. K. Kondo Congenital Minamata disease: warnings from Japan's experience J Child Neurol 15 2000 458 464
28. M. Harada Minamata disease: methylmercury poisoning in Japan caused by environmental pollution Crit Rev Toxicol 25 1995 1 24
29. L.G. Tedeschi The Minamata disease Am J Forensic Med Pathol 3 1982 335 338
30. K. Tsuchiya The discovery of the causal agent of Minamata disease Am J Ind Med 21 1992 275 280
31. J.J. Putman Quicksilver and slow death National Geographic October 1972 506 527
32. Y. Harada, and K. Noda How it came about the finding of methyl mercury poisoning in Minamata district Congenital Anomalies 28 Suppl October 1988 S59 S69
33. D. Hunter, R.R. Bomford, and D.S. Russell Poisoning by methylmercury compounds Q J Med 9 1940 193 213
34. K. Eto Minamata disease Neuropathology 20 Suppl 2000 S14 S19
35. K. Eto, H. Tokunaga, and K. Nagashima An autopsy case of minamata disease (methylmercury poisoning)-pathological viewpoints of peripheral nerves Toxicol Pathol 30 2002 714 722
36. M. Harada Congenital Minamata disease: intrauterine methylmercury poisoning Teratology 18 1978 285 288
37. J. Watts Mercury poisoning victims could increase by 20,000 Lancet 358 2001 1349
38. F. Bakir, S.F. Damluji, and L. Amin-Zaki Methylmercury poisoning in Iraq Science 181 1973 230 241
39. A. Hviid, M. Stellfeld, and J. Wohlfahrt Association between thimerosal-containing vaccine and autism JAMA 290 2003 1763 1766
40. J.W. Langston, and J. Palfreman The case of the frozen addicts 1995 Pantheon Books New York
41. The case of the frozen addict [transcript]. "NOVA". PBS Television. February 18, 1986.
42. G.C. Davis, A.C. Williams, and S.P. Markey Chronic Parkinsonism secondary to intravenous injection of meperidine analogues Psychiatry Res 1 1979 249 254
43. J.W. Langston, P. Ballard, and J.W. Tetrud Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 1983 979 980
44. K. Chiba, A. Trevor, and N. Castagnoli Jr. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase Biochem Biophys Res Commun 120 1984 574 578
45. J.W. Langston, I. Irwin, and E.B. Langston Pargyline prevents MPTP-induced parkinsonism in primates Science 225 1984 1480 1482
46. K. Chiba, A.J. Trevor, and N. Castagnoli Jr. Active uptake of MPP +, a metabolite of MPTP, by brain synaptosomes Biochem Biophys Res Commun 128 1985 1228 1232 1216
47. W.J. Nicklas, I. Vyas, and R.E. Heikkila Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1, 2,5,6-tetrahydropyridine Life Sci 36 1985 2503 2508
48. W.J. Nicklas, S.K. Youngster, and M.V. Kindt MPTP, MPP + and mitochondrial function Life Sci 40 1987 721 729
49. P.A. Loschmann, K.W. Lange, and H. Wachtel MPTP-induced degeneration: interference with glutamatergic toxicity J Neural Transm Suppl 43 1994 133 143
50. J.W. Tetrud, and J.W. Langston The effect of deprenyl (selegiline) on the natural history of Parkinson's disease Science 245 1989 519 522
51. C.M. Tanner, R. Ottman, and S.M. Goldman Parkinson disease in twins: an etiologic study JAMA 281 1999 341 346
52. P. Piccini, D.J. Burn, and R. Ceravolo The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins Ann Neurol 45 1999 577 582
53. A. Woolf Witchcraft or mycotoxin? The Salem witch trials J Trace Elem Electrolytes Health Dis 38 2000 457 460
54. M.J. Eadie Convulsive ergotism: epidemics of the serotonin syndrome? Lancet 2 2003 429 434
55. S. Christopoulos, A. Szilagyi, and S.R. Kahn Saint-Anthony's fire Lancet 358 2001 1694
56. C. De Costa St Anthony's fire and living ligatures: a short history of ergometrine Lancet 359 2002 1768 1770
57. H.W. Dudley, and C. Moir The substance responsible for the traditional clinical effect of ergot BMJ 1 1935 520 523
58. Z.K. Baldwin, and C.C. Ceraldi Ergotism associated with HIV antiviral protease inhibitor therapy J Vector Ecol 37 2003 676 678